These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Comparison of peritoneal equilibrium test with icodextrin and 2.5% glucose dialysis solutions. Hwang JC, Wang HY, Wang CT, Chen HC. J Nephrol; 2006 Oct; 19(6):758-63. PubMed ID: 17173249 [Abstract] [Full Text] [Related]
51. Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload. Johnson DW, Arndt M, O'Shea A, Watt R, Hamilton J, Vincent K. BMC Nephrol; 2001 Dec 03; 2():2. PubMed ID: 11737871 [Abstract] [Full Text] [Related]
52. Peritoneal transport characteristics with glycerol-based dialysate in peritoneal dialysis. Smit W, de Waart DR, Struijk DG, Krediet RT. Perit Dial Int; 2000 Dec 03; 20(5):557-65. PubMed ID: 11117247 [Abstract] [Full Text] [Related]
56. Effects of Steady Glucose Concentration Peritoneal Dialysis on Ultrafiltration Volume and Sodium Removal: A Pilot Crossover Trial. Heimbürger O, Hegbrant J, Martus G, Wilkie M, De Leon C, Carlsson O, Johansson AC. Clin J Am Soc Nephrol; 2024 Feb 01; 19(2):224-232. PubMed ID: 37902732 [Abstract] [Full Text] [Related]
57. Glycated adducts induce mesothelial cell transdifferentiation: role of glucose and icodextrin dialysis solutions. Conti G, Amore A, Cirina P, Peruzzi L, Balegno S, Coppo R. J Nephrol; 2008 Feb 01; 21(3):426-37. PubMed ID: 18587733 [Abstract] [Full Text] [Related]
58. Sodium removal and peritoneal dialysis modalities: no differences with optimal prescription of icodextrin. Fourtounas C, Dousdampanis P, Hardalias A, Vlachojannis JG. Artif Organs; 2013 Jul 01; 37(7):E107-13. PubMed ID: 23461737 [Abstract] [Full Text] [Related]